In the Boardroom
Refine Search
Pharmaceutical
French independent pharma company Servier says it has appointed David Lee to its executive committee as executive vice president for the United States, effective January 1, 2025. 13 January 2025
Pharmaceutical
Medicines Discovery Catapult (MDC), the UK government-backed life sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its executive team with the appointment of a chief commercial officer (CCO) and its first managing director (MD). 13 January 2025
Pharmaceutical
Artbio, a radiopharmaceutical company developing a new class of targeted alpha radioligand therapies (ARTs), has named Margaret Yu its chief medical officer (CMO). 10 January 2025
Pharmaceutical
UK headquartered Verdiva Bio Limited today announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. 9 January 2025
Pharmaceutical
German family-owned pain focused drugmaker Grünenthal announced today that Prof Dr Uli Brödl will assume the role of chief scientific officer (CSO) and a member of the corporate executive board, effective February 1, 2025. 9 January 2025
Pharmaceutical
Antag Therapeutics, a Denmark-based biopharma developing novel treatments for obesity, has announced the appointment of Joerg Moeller as chief executive officer, effective immediately. 8 January 2025
Pharmaceutical
Alon Natanson, a business leader and alumnus of the Hebrew University of Jerusalem, has been appointed chief executive officer (CEO) of Yissum, the Israeli Hebrew University Tech Transfer company. 6 January 2025
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
Sweden’s Karolinska Development says that Bo Jesper Hansen, chairman of the company's board, has decided not stand for re-election at the 2017 Annual General Meeting. 20 April 2017
Pharmaceutical
French drugmaker Ipsen on Friday announced the appointment of Dr Alexandre Lebeaut as executive vice-president, R&D, and chief scientific officer, effective immediately. 18 April 2017
Pharmaceutical
In a finding that might add weight to industry calls for continued free movement of vital talent post-Brexit, a study has shown that country managers and European heads in UK pharma are far more internationally diverse than their French and German counterparts. 12 April 2017
Pharmaceutical
Takeda Pharmaceuticals says that Ricardo Marek has been appointed as the president of the Emerging Markets Business Unit (EM BU), based in Singapore, effective April 1, 2017 31 March 2017
Pharmaceutical
Takeda Pharmaceutical said today that Giles Platford will assume the role of president of its Europe and Canada (EUCAN) business unit. In this role he will lead business operations in the region effective April 1, 2017. 30 March 2017
Pharmaceutical
Claude Bertrand started on Monday in his new role as general director of research and development (R&D) and chief scientific officer (CSO) at privately-held French drugmaker Servier. 27 March 2017
Pharmaceutical
The US subsidiary of Japanese pharma major Eisai has appointed Kirk Shepard as senior vice president, global medical affairs of the Oncology Business Group. 17 March 2017
Pharmaceutical
US pharma major Bristol-Myers Squibb has appointed Dr Thomas Lynch, Jr, as executive vice president and chief scientific officer, effective March 16, 2017. 9 March 2017
Pharmaceutical
Denmark-based allergy specialist ALK-Abelló has appointed Hendrik Nolte as senior vice president of R&D for North America and International Markets, based in the USA. 3 March 2017
Pharmaceutical
French drugmaker Ipsen has appointed Benoit Hennion as executive vice president and president of primary care. 2 March 2017
Pharmaceutical
Investors in Ireland-incorporated Perrigo probably did not know where to turn on Monday and Tuesday amid news on the company’s management, job cuts, divestment of royalty payment rights on a multiple sclerosis drug and its publication of bleak financial guidance. 1 March 2017
Pharmaceutical
Jakob Riis, executive vice president, head of North America Operations and president of Novo Nordisk Inc, has resigned, Danish diabetes care giant Novo Nordisk announced this morning. 1 March 2017
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Nathalie Moll as its new director general. 22 February 2017
Pharmaceutical
US pharma major Bristol-Myers Squibb has announced the appointment to the board of three new independent directors. 22 February 2017
Pharmaceutical
Teijin Pharma, the core company of Japan’s Teijin Group’s healthcare business, says that its board of directors has elected Akihisa Nabeshima as its next president. 22 February 2017
Pharmaceutical
A pharma veteran has switched from one of the industry’s giants to another to lead its UK pharmaceuticals business. 15 February 2017
Pharmaceutical
While last week’s news continued to be dominated by actions of newly-installed US President Donald Trump, including the vote to approve his controversial nominee Dr Tom Price as Secretary of Health and Human Services, the pharma industry itself was also making headlines. 12 February 2017
Pharmaceutical
Christine Lind has been appointed as the new chief executive of Swedish drugmaker Medivir. 9 February 2017
Pharmaceutical
French drugmaker Ipsen has added years of big pharma experience to its executive and research and development (R&D) leadership teams. 7 February 2017
Pharmaceutical
Thomas Cueni has taken up office as director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on February 1, representing the interests of the research-based biopharmaceutical industry at a global level. 7 February 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze